nirogacestat

5 Highly Anticipated FDA Decisions for Rare Diseases Coming This Year
BioSpace
Fri, 07/28/23 - 11:46 am
Ipsen
palovarotene
fibrodysplasia ossificans progressiva
Regeneron
CHAPLE disease
pozelimab
Biomarin
Voxzogo
achondroplasia
Santhera Pharmaceuticals
vamorolone
DMD
Springworks
nirogacestat
desmoid tumors
Pfizer spinout SpringWorks gets FDA priority review for lead drug
Endpoints
Mon, 02/27/23 - 10:14 am
SpringWorks Therapeutics
Pfizer
nirogacestat
desmoid tumors
FDA
priority review
SpringWorks, Eli Lilly and More Release Data Ahead of ESMO
BioSpace
Thu, 09/8/22 - 04:30 pm
SpringWorks Therapeutics
nirogacestat
desmoid tumors
Eli Lilly
ESMO
Pfizer spinout SpringWorks will ship its first drug to the FDA before year’s end with PhIII win
Endpoints
Tue, 05/24/22 - 10:46 am
Pfizer
SpringWorks Therapeutics
spinoffs
oncology
FDA
clinical trials
nirogacestat
desmoid tumors
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial
Xconomy
Mon, 01/13/20 - 10:25 am
SpringWorks Therapeutics
Allogene
Multiple Myeloma
clinical trials
ALLO-715
nirogacestat
SpringWorks Therapeutics Updates Filing for $143+ Million IPO
CP Wire
Tue, 09/3/19 - 10:26 am
SpringWorks Therapeutics
IPOs
nirogacestat
mirdametinib
Pfizer
SpringWorks Therapeutics Updates Filing for $143+ Million IPO
Tue, 09/3/19 - 09:50 am
SpringWorks Therapeutics
IPOs
nirogacestat
mirdametinib
Pfizer
Pfizer biotech spinout nabs $125M megaround as Bain-backed syndicate bets on its late-stage game plan
Endpoints
Mon, 04/1/19 - 12:35 pm
Pfizer
SpringWorks Therapeutics
nirogacestat
PD-0325901